BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30585550)

  • 41. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.
    Lançon A; Hanet N; Jannin B; Delmas D; Heydel JM; Lizard G; Chagnon MC; Artur Y; Latruffe N
    Drug Metab Dispos; 2007 May; 35(5):699-703. PubMed ID: 17287390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
    Norris GH; Blesso CN
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
    Bzdęga W; Kurzyna PF; Harasim-Symbor E; Hołownia A; Chabowski A; Konstantynowicz-Nowicka K
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells.
    Poolsri WA; Phokrai P; Suwankulanan S; Phakdeeto N; Phunsomboon P; Pekthong D; Richert L; Pongcharoen S; Srisawang P
    Biomed Res Int; 2018; 2018():3683026. PubMed ID: 29546056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
    Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Automated untargeted stable isotope assisted lipidomics of liver cells on high glucose shows alteration of sphingolipid kinetics.
    Noto D; Di Gaudio F; Altieri IG; Cefalù AB; Indelicato S; Fayer F; Spina R; Scrimali C; Giammanco A; Mattina A; Indelicato S; Greco M; Bongiorno D; Averna M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158656. PubMed ID: 32045699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase.
    Facchinetti MM; Beuret C; Marquez MG; Sterin-Speziale N
    Biol Neonate; 2003; 84(3):243-51. PubMed ID: 14504448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Widespread tissue distribution and synthetic pathway of polyunsaturated C24:2 sphingolipids in mammals.
    Edagawa M; Sawai M; Ohno Y; Kihara A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Dec; 1863(12):1441-1448. PubMed ID: 30251650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
    Kurek K; Garbowska M; Ziembicka DM; Łukaszuk B; Rogowski J; Chabowski A; Górski J; Żendzian-Piotrowska M
    Adv Med Sci; 2017 Mar; 62(1):65-73. PubMed ID: 28189121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.
    Morad SA; Tan SF; Feith DJ; Kester M; Claxton DF; Loughran TP; Barth BM; Fox TE; Cabot MC
    Biochim Biophys Acta; 2015 Jul; 1851(7):919-28. PubMed ID: 25769964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity.
    Hodun K; Sztolsztener K; Chabowski A
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Quercetin and Fingolimod, Alone or in Combination, on the Sphingolipid Metabolism in HepG2 Cells.
    Momchilova A; Nikolaev G; Pankov S; Vassileva E; Krastev N; Robev B; Krastev D; Pinkas A; Pankov R
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sphingolipid-Transporting Proteins as Cancer Therapeutic Targets.
    Samaha D; Hamdo HH; Wilde M; Prause K; Arenz C
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocytic pathways of optimized resveratrol cubosomes capturing into human hepatoma cells.
    Abdel-Bar HM; El Basset Sanad RA
    Biomed Pharmacother; 2017 Sep; 93():561-569. PubMed ID: 28686970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
    Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
    Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New evidence for the role of ceramide in the development of hepatic insulin resistance.
    Konstantynowicz-Nowicka K; Harasim E; Baranowski M; Chabowski A
    PLoS One; 2015; 10(1):e0116858. PubMed ID: 25635851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The novel resveratrol derivative 3,5-diethoxy-3',4'-dihydroxy-trans-stilbene induces mitochondrial ROS-mediated ER stress and cell death in human hepatoma cells in vitro.
    Park JW; Choi WG; Lee PJ; Chung SW; Kim BS; Chung HT; Cho S; Kim JH; Kang BH; Kim H; Kim HP; Back SH
    Acta Pharmacol Sin; 2017 Nov; 38(11):1486-1500. PubMed ID: 28795692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
    Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
    Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.